Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | IDH2 |
| Variant | R172S |
| Impact List | missense |
| Protein Effect | gain of function |
| Gene Variant Descriptions | IDH2 R172S lies within the active site of the Idh2 protein (PMID: 19228619). R172S confers a gain of function to the Idh2 protein as demonstrated by accumulation 2HG (R(-)-2-hydroxyglutarate), and leads to increased migration in cultured cells (PMID: 23264629, PMID: 27913435). |
| Associated Drug Resistance | |
| Category Variants Paths |
IDH2 mutant IDH2 act mut IDH2 R172S IDH2 mutant IDH2 R172X IDH2 R172S |
| Transcript | NM_002168.4 |
| gDNA | chr15:g.90088605C>G |
| cDNA | c.516G>C |
| Protein | p.R172S |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_002168 | chr15:g.90088605C>G | c.516G>C | p.R172S | RefSeq | GRCh38/hg38 |
| NM_002168.4 | chr15:g.90088605C>G | c.516G>C | p.R172S | RefSeq | GRCh38/hg38 |
| NM_002168.3 | chr15:g.90088605C>G | c.516G>C | p.R172S | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04164901 | Phase III | Vorasidenib | Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) | Active, not recruiting | USA | NLD | ITA | ISR | GBR | FRA | ESP | DEU | CHE | CAN | 1 |
| NCT03953898 | Phase II | Olaparib | Using the Anticancer Drug Olaparib to Treat Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome With an Isocitrate Dehydrogenase (IDH) Mutation | Active, not recruiting | USA | 0 |